04/27/2021
6:00 AM | Molecular Templates (Filer)
| Form DEF 14A
| |
04/26/2021
12:11 PM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
04/21/2021
10:22 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2021
12:14 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2021
11:26 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2021
2:51 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2021
12:52 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2021
12:13 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2021
6:38 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2021
12:44 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/19/2021
5:52 AM | Molecular Templates (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/19/2021
5:10 AM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
1:46 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
3:36 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2021
4:28 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
4:00 PM | Molecular Templates (Filer)
| Form 424B5
| |
02/17/2021
4:02 PM | Cutler Adam D. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:55 PM | Molecular Templates (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2021
3:14 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2021
2:41 PM | Molecular Templates (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A
| |
02/12/2021
4:07 PM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
02/11/2021
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
02/11/2021
6:36 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2021
12:33 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2021
3:58 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2021
7:00 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2020
11:36 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2020
5:30 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2020
3:09 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2020
5:04 AM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2020
3:32 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
2:05 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2020
7:53 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/18/2020
3:39 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2020
3:38 PM | Cunningham Joe H (Reporting)
FRENCH DOUGLAS D (Reporting)
Molecular Templates (Issuer)
Sante Health Ventures I Annex Fund, LP (Reporting)
SANTE HEALTH VENTURES I LP (Reporting)
SHV Annex Services, LP (Reporting)
SHV Management Services, LLC (Reporting)
SHV Management Services, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2020
6:33 PM | ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
11:15 PM | Molecular Templates (Filer)
| Form EFFECT
| |
08/17/2020
3:21 PM | Molecular Templates (Filer)
| Form 424B5
| |
08/07/2020
6:19 AM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/07/2020
6:00 AM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/20/2020
3:30 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2020
11:15 PM | Molecular Templates (Filer)
| Form EFFECT
| |
06/16/2020
3:32 PM | Molecular Templates (Filer)
| Form S-3/A
| |
06/05/2020
4:11 PM | Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13D/A
| |
06/04/2020
3:42 PM | Molecular Templates (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/01/2020
4:09 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:09 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:09 PM | Hirsch David (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:06 PM | Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2020
4:05 PM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2020
8:13 PM | Hirsch David (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2020
8:07 PM | ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2020
4:10 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2020
3:16 PM | Cunningham Joe H (Reporting)
FRENCH DOUGLAS D (Reporting)
Molecular Templates (Issuer)
Sante Health Ventures I Annex Fund, LP (Reporting)
SANTE HEALTH VENTURES I LP (Reporting)
SHV Annex Services, LP (Reporting)
SHV Management Services, LLC (Reporting)
SHV Management Services, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2020
7:20 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2020
5:00 AM | Molecular Templates (Filer)
| Form NT 10-Q
| |
04/23/2020
3:05 PM | Molecular Templates (Filer)
| Form DEF 14A
| |
03/13/2020
9:27 AM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/18/2020
8:59 PM | Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
8:59 PM | Cutler Adam D. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
8:59 PM | Molecular Templates (Issuer)
Poma Eric E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
8:58 PM | Kim Jason S. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
2:21 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
01/29/2020
3:34 PM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G
| |
01/03/2020
3:41 PM | Kim Jason S. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2019
7:05 AM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2019
7:00 AM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2019
4:23 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2019
3:29 PM | Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
| Form SC 13D/A
| |
12/05/2019
3:16 PM | Hirsch David (Reporting)
Molecular Templates (Issuer)
| Form 4/A
| |
12/05/2019
3:16 PM | ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
| Form 4/A
| |
11/27/2019
3:47 PM | ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2019
3:43 PM | Hirsch David (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2019
10:38 AM | Molecular Templates (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/25/2019
3:24 PM | CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2019
8:01 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2019
6:37 PM | Molecular Templates (Filer)
| Form 424B5
| |
11/20/2019
3:48 PM | Molecular Templates (Filer)
| Form 424B5
| |
11/18/2019
6:09 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
4:00 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2019
7:01 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2019
3:32 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2019
3:30 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2019
7:04 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
7:02 PM | HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
6:58 PM | Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
6:57 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2019
6:55 PM | Hirsch David (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2019
3:34 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2019
3:45 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2019
3:02 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2019
3:45 PM | Molecular Templates (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2019
3:14 PM | Molecular Templates (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2019
3:30 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2019
11:40 AM | Molecular Templates (Filer)
| Form CT ORDER
| |
02/21/2019
3:56 PM | Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2019
3:31 PM | Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2019
3:29 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
02/13/2019
3:15 PM | Molecular Templates (Filer)
| Form 10-Q/A
| |
02/06/2019
8:44 AM | Excel Venture Fund II, L.P. (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A
| |
